| Product Code: ETC13158298 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Personalized Cancer Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Personalized Cancer Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Africa Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.8 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.10 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.11 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Africa Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Personalized Cancer Vaccines Market Trends |
6 Africa Personalized Cancer Vaccines Market, 2021 - 2031 |
6.1 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.1.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.1.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.1.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Leukaemia, 2021 - 2031 |
6.1.6 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.1.7 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Cervical Cancer, 2021 - 2031 |
6.1.8 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Glioblastoma, 2021 - 2031 |
6.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Mechanism of Action Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021 - 2031 |
6.2.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021 - 2031 |
6.2.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021 - 2031 |
6.2.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021 - 2031 |
6.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021 - 2031 |
6.3.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Recombinant Cancer Vaccines, 2021 - 2031 |
6.3.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021 - 2031 |
6.3.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021 - 2031 |
6.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Pharmacogenomics, 2021 - 2031 |
6.4.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021 - 2031 |
6.4.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Immune Checkpoint Biomarkers, 2021 - 2031 |
6.4.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Preventive Cancer Vaccines, 2021 - 2031 |
6.5.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Therapeutic Cancer Vaccines, 2021 - 2031 |
6.6 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Injectables, 2021 - 2031 |
6.6.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.7.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.7.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Personalized Cancer Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3 Africa Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
7.3.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Mechanism of Action Type, 2021 - 2031 |
7.3.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Mechanism of Action Type, 2021 - 2031 |
7.3.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Mechanism of Action Type, 2021 - 2031 |
7.3.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Mechanism of Action Type, 2021 - 2031 |
7.4 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
7.5.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
7.5.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
7.5.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
7.5.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Bio-Maker Type, 2021 - 2031 |
7.6 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.6.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.6.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.6.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.6.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.7 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 Africa Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.8.1 South Africa Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.8.2 Egypt Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.8.3 Nigeria Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.8.4 Rest of Africa Personalized Cancer Vaccines Market, Revenues & Volume, By End Users, 2021 - 2031 |
8 Africa Personalized Cancer Vaccines Market Key Performance Indicators |
9 Africa Personalized Cancer Vaccines Market - Export/Import By Countries Assessment |
10 Africa Personalized Cancer Vaccines Market - Opportunity Assessment |
10.1 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.3 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
10.4 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
10.6 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.7 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.8 Africa Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
11 Africa Personalized Cancer Vaccines Market - Competitive Landscape |
11.1 Africa Personalized Cancer Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Africa Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here